Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

Clinical trial NCT01530711 · UNKNOWN

Trial details

NCT number: NCT01530711
Sponsor: Pere Gines
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Cirrhosis Hepatorenal Syndrome Type I

Start date: 2012-04-01
Primary completion: 2016-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.